Mr Samuel Bishara

Mr Samuel Bishara is a Consultant Urologist with a specialist interest in minimally invasive treatments for benign prostatic hyperplasia, stone disease, bladder dysfunction, and incontinence.

He graduated from the University of Bristol and completed his basic surgical training at University College London Hospitals (UCLH), obtaining his Membership of the Royal College of Surgeons (MRCS) in 2003. His early interest in urology developed during Senior House Officer (SHO) posts at UCLH and the Royal Marsden Hospital.

In 2010, Mr Bishara completed a Doctorate in Medicine (MD) at University College London, focusing on bladder overactivity. He went on to undertake higher specialist training in urology through the North London training programme, where he developed expertise in the management of stone disease, prostate conditions, and urinary incontinence.

Mr Bishara is currently a Consultant Urologist at Chelsea and Westminster Hospital NHS Foundation Trust. He has a broad interest in teaching and clinical research and has published and presented widely in the fields of bladder dysfunction, urological oncology, and stone disease.

He has been instrumental in developing minimally invasive urological services within the Trust. Notably, he was among the first urologists in the UK to perform echolaser or transperineal laser ablation of the prostate—a novel, local anaesthetic treatment for benign prostatic hyperplasia (BPH) with no associated risk of erectile dysfunction or incontinence. Having received training in Italy, Mr Bishara successfully introduced the technique at his Trust and has achieved excellent outcomes. He regularly leads training workshops for other consultants to support the wider adoption of the procedure across the NHS.

In addition, he has introduced the I-TIND implant—a minimally invasive therapy for BPH—into clinical use at the Trust. He has also introduced to his trust a novel form of posterior tibial nerve stimulation for overactive bladder, which allows patients to carry out treatment at home. This innovation was supported by a competitive grant award.

To enhance the experience of patients undergoing procedures under local anaesthetic, Mr Bishara has introduced the use of virtual reality (VR) goggles to reduce intra-operative pain and anxiety. This initiative was also recognised and funded through a grant from CW+.

Patient FeedbackMr Samuel Bishara takes his patient feedback seriously, aiming to provide the highest quality of care. Below are some recent patient testimonies:

“I recently had a TURP operation carried out by Mr Bishara. It came as no surprise to him that the procedure was a complete success, and completely achieved the outcome he had predicted.
But from my point of view, although wonderful in itself, that was only part of the story. Mr Bishara’s major concern and sympathy throughout was that my quality of life had been severely restricted by my condition, and that his aim was to achieve normality for me.
At every stage he kept me fully informed as to the nature of the procedure, the potential risks involved as well as the benefits I should gain well into the future.
I cannot recommend Mr Bishara highly enough.”

“Mr Bishara had a complete understanding of the effect of my condition on my quality of life and approached it from that angle.”

“Mr Samuel Bishara listened and explained all options to the next stages.”

Recent PublicationsChatterjee A, Ali I, Wong F, Allen-Tejerina AM, Chatzikrachtis N, McComb K, Bishara S, De Caluwe D, Zavras N, Norris JM, Nikolinakos P. A protocol for systematic review which is being carried out to assess the efficacy of Methenamine hippurate for the management and prophylaxis of recurrent urinary tract infections. BMJ Open. 2025 Apr 30;15(4):e100458. doi:10.1136/bmjopen-2025-100458.

Fallon P, Chatterjee A, Chatzikrachtis N, Sapountzis D, Donkov I, Bishara S, Charitopoulos K, Nikolinakos P. Migrating staghorn calculus secondary to a renocolic fistula: a case report and review of the literature. Case Rep Urol. 2025 Feb 26;2025:1014938. doi:10.1155/criu/1014938.

Sim A, Nikolinakos P, Charitopoulos K, Donkov I, Bishara S. Vasectomy histology: is it still useful? Arch Ital Urol Androl. 2024 Oct 2;96(3):12682. doi:10.4081/aiua.2024.12682.

Nikolinakos P, Chatzikrachtis N, Chatterjee A, Donkov I, Bishara S, Kotsi E, Alexandrou I, Zavras N, Norris JM. Comparison of outcomes of open, laparoscopic and robot-assisted laparoscopic pyeloplasty in children with ureteropelvic junction obstruction: protocol for a systematic review and meta-analysis. BMJ Open. 2024 Aug 30;14(8):e087519. doi:10.1136/bmjopen-2023-087519.

Bishara S. Adapting power calculations to include a superiority margin: what are the implications? Biochem Med (Zagreb). 2024 Feb 15;34(1):010101. doi:10.11613/BM.2024.010101.

Mukherjee S, Papadopoulos D, Chari N, Ellis D, Charitopoulos K, Charitopoulos I, Bishara S. High-grade prostate cancer demonstrates preferential growth in the cranio-caudal axis and provides discrimination of disease grade in an MRI parametric model. Br J Radiol. 2024 Mar;97(1155):574–582. doi:10.1093/bjr/tqad066.

Nikolinakos P, Sapountzis D, Donkov I, Bishara S, Charitopoulos K, Ellis D, Ali MK, Velaoras K, Alexandrou I, Zavras N, Norris JM. Comment Re: Early experience with pediatric single-port robotic 

Clinical Interests

Urinary Symptoms

Incontinence

Prostatitis

Pelvic Pain

Painful bladder syndrome

Transperineal prostate biopsy

Haematuria investigation

Superficial bladder cancer

Upper tract transitional cell carcinoma

Prostate Surgery

Urodynamics and video urodynamics

Ureteric and renal stones

Renal stone prevention

Erectile dysfunction

Penile and scrotal surgery

Testicular Cancer